The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties.
about
N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor bindingGlycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects.Stoichiometry of interaction between interferon gamma and its receptorOptimization of the medium perfusion rate in a packed-bed bioreactor charged with CHO cellsOverloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time.Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis.Selective identification and differentiation of N- and O-linked oligosaccharides in glycoproteins by liquid chromatography-mass spectrometry.Expression of a recombinant elastin-like protein in pichia pastoris.Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.Enhancement of human prolactin synthesis by sodium butyrate addition to serum-free CHO cell culture.Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.Dose-exposure proportionality of a novel recombinant follicle-stimulating hormone (rFSH), FE 999049, derived from a human cell line, with comparison between Caucasian and Japanese women after subcutaneous administrationEvidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis.The importance of cell physiology to the performance of animal cell bioreactors.Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis.Heterologous protein production using the Pichia pastoris expression system.A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.Model-based analysis of N-glycosylation in Chinese hamster ovary cells.Structural analysis and localization of the carbohydrate moieties of a soluble human interferon gamma receptor produced in baculovirus-infected insect cells.Glycosylation: impact, control and improvement during therapeutic protein production.Improving the secretory production of the heterologous protein in Pichia pastoris by focusing on protein folding.Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator.Expression of human recombinant beta 2-glycoprotein I with anticardiolipin antibody cofactor activity.Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line.Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.Fed-batch CHO cell t-PA production and feed glutamine replacement to reduce ammonia production.Expression of codon optimized human bone morphogenetic protein 4 in Pichia pastoris.Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity.Isolation and characterization of a subset of erythropoietin glycoforms with cytoprotective but minimal erythropoietic activity.Effects of cell culture conditions on antibody N-linked glycosylation--what affects high mannose 5 glycoform.Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.Characterization of the proteases involved in the N-terminal clipping of glucagon-like-peptide-1-antibody fusion proteins.Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH.Streptomyces lividans glycosylates the linker region of a beta-1,4-glycanase from Cellulomonas fimi.Overview of protein expression by mammalian cells.Influence of culture medium supplementation of tobacco NT1 cell suspension cultures on the N-glycosylation of human secreted alkaline phosphatase.Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor.
P2860
Q28250986-1AEBE861-E501-4EBD-9CA7-C69CA996841EQ28378562-ABCF6CBB-EA35-4DB0-B0F3-73D0681DB16AQ28646266-1CD47EF2-99ED-4298-BF9F-EDC9E8015D46Q30462042-6042C77F-4752-4F9C-84F4-254BE4693996Q30832956-6BA7BF23-65A5-4FE7-926D-7A955CD06D89Q30987721-14BB4A38-F74C-4409-9147-FC4A3559FC58Q33484061-1582EE96-251E-4506-A1F7-EBF2C8B93FE5Q33510375-95B1E0E1-8E75-4ACE-B051-2188D54C04F8Q33883354-8BF9AD61-0766-490B-B764-2022C8B125A5Q33960056-110DBA9D-52BA-4DA6-B9F5-AA4E26B7AB4FQ34371501-47C1F9D5-4A4E-4616-ADD7-250349100F01Q35203531-48E7A9A2-C6A0-43D0-A9AC-46837DB7E347Q35426482-B50860E7-81D6-4244-9C00-E4C63B4A55E3Q35446633-7BFAAC29-BF06-4C96-BEB2-22C0F88D2074Q35606285-57715D70-51A4-4E3D-BD61-5BA7FB84E608Q36036987-36969A44-12FD-4A8F-9A22-8501F3C6CEEDQ36365516-B1923AED-1973-440A-91A5-18A606837683Q36366942-E8E74F44-EF9A-4296-A8CE-E10210EB4811Q36745882-0968494B-929E-47D2-BE9A-2ADD648C6436Q38126913-5ED20FB6-64B6-434E-86BB-C895A5CDD898Q38261153-385556EB-AF60-4A16-94D4-A0DF49E2DC26Q38309412-6AF19424-3F06-4B8C-863E-E93A6C5DE72BQ38317583-8128C5FD-C2F0-4B6E-9504-CF8157B945DBQ38956580-4A68E9E3-D8DB-4615-B9C9-FE29FBE0587CQ38987190-C833D6D4-6FD3-4F15-BA85-D2FA4AFD008DQ38997997-8C6EF417-6AD1-40EE-A414-144EEBA32985Q39149359-C79A30DB-57C1-4C0E-9317-080D07357911Q39249582-F704FA6F-DA1E-468C-88C2-D13F9AB37616Q39367682-625CD724-695E-43B8-8689-A4337AAF24BAQ39484103-EDF87AFA-F266-43FD-94C7-38424A9DBA7BQ39537317-B85F4FA0-19DF-4256-8C5F-33680B7BDB24Q39545373-DFFBD712-329B-4497-AB57-A76B4C000E46Q39580367-AC7A9412-6B9B-484C-874C-EA7B8216C436Q39590627-3DCEB7E7-B883-49A6-B9C7-E3AE095E2440Q39594082-012E2CF2-66AB-4405-99E5-E9BA2D8D32A5Q39616628-9A39E98A-634E-48F7-BB9B-3AD765129434Q39930572-B67D0D29-B391-4D84-85EA-2EB3401A584BQ39989577-55522D6F-F76B-4946-865B-BC81264392BEQ40180944-642CC162-75BB-4226-8CC1-2CA255853339Q40761319-3DE15AB5-94A7-49C4-9267-5A23CB2EB56F
P2860
The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties.
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@ast
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@en
type
label
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@ast
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@en
prefLabel
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@ast
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@en
P2093
P2860
P356
P1433
P1476
The oligosaccharides of glycop ...... ct on glycoprotein properties.
@en
P2093
Andersen DC
Goochee CF
Rasmussen JR
P2860
P2888
P304
P356
10.1038/NBT1291-1347
P577
1991-12-01T00:00:00Z
P5875
P6179
1051718868